Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K024223
    Manufacturer
    Date Cleared
    2003-01-13

    (21 days)

    Product Code
    Regulation Number
    866.5100
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Liquichek Anti-RNP Control, Positive, is intended for use as an unassayed quality control to monitor indirect immunofluorescent testing for the detection of ribonucleoprotein (RNP) autoantibodies.

    Device Description

    This product is prepared from human serum with added preservatives. The control is provided in liquid form for convenience.

    AI/ML Overview

    This document describes a submission for a quality control device, not a diagnostic device that performs analysis on patient samples. Therefore, many of the requested fields are not applicable in this context.

    Here's an analysis based on the provided text:

    Acceptance Criteria and Device Performance (Not Applicable - This is a Quality Control Device)

    This document describes a "Liquichek™ Anti-RNP Control, Positive" which is an unassayed quality control intended to monitor indirect immunofluorescent testing. It is not a diagnostic device that directly detects disease or provides a patient result. Therefore, the concept of "acceptance criteria" for a diagnostic performance (like sensitivity, specificity, accuracy) and "device performance" in terms of clinical outcomes or diagnostic accuracy are not applicable to this product.

    Instead, the "performance" for a quality control device is typically related to its stability and its ability to consistently produce an expected qualitative result (e.g., positive). The acceptance criteria for this type of product would revolve around ensuring the control material remains stable and retains its intended properties for its labeled shelf-life and open-vial stability.

    The Study Proving the Device Meets Criteria:

    The study described is a stability study.

    1. Table of Acceptance Criteria and Reported Device Performance:

    Acceptance Criteria (for a Quality Control Device)Reported Device Performance
    Open-vial stability: Analyte stable for 60 days when stored tightly capped at 2 to 8°C.The control remained stable for 60 days once opened when stored at 2-8°C, tightly capped.
    Shelf-life: Control stable for 2 years when stored unopened at 2-8°C.The control remained stable for 2 years when stored unopened at 2-8°C.

    Note: The document implies these were the performance claims derived from the stability studies, rather than explicitly stating pre-defined "acceptance criteria" in a numerical format. For a quality control, the "performance" is its ability to remain stable and provide the expected qualitative result for the specified duration.

    2. Sample size used for the test set and the data provenance:

    • Sample Size: Not explicitly stated for either stability study. The studies likely involved multiple vials of the control material tested at various time points.
    • Data Provenance: Not specified, but generally, stability studies for medical devices are conducted at the manufacturer's facility (Bio-Rad Laboratories). The study type is prospective for the duration of the stability testing.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not Applicable. This is a quality control device. "Ground truth" in the clinical sense (e.g., disease presence) is not established for the control material itself. The "truth" for a control is its known positive reactivity for the target analyte, which is inherent in its manufacture.

    4. Adjudication method for the test set:

    • Not Applicable. As this is a quality control device undergoing stability testing, an adjudication method like 2+1 or 3+1 is not relevant. The stability evaluation typically involves analytical testing to confirm the continued reactivity and stability of the control material over time.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • Not Applicable. This is a quality control device, not an AI-powered diagnostic tool, and involves no human readers or AI assistance in its primary function.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    • Not Applicable. This is a quality control device, not an algorithm or AI system.

    7. The type of ground truth used:

    • Not Applicable in the traditional sense of patient diagnosis. For a quality control material, the "truth" is its inherent composition and known reactivity for the specified analyte (Anti-RNP). This is established during its manufacturing process.

    8. The sample size for the training set:

    • Not Applicable. This is a quality control device and does not involve a "training set" in the context of machine learning or algorithm development.

    9. How the ground truth for the training set was established:

    • Not Applicable. See point 8.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1